SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 10-K
Document Type: EX-19.1
Date Filed: 2025-03-31
Accession Number: 0001213900-25-026254
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025026254/ea023575801ex19-1_synergy.htm

Chunk 3 of 4
Word Count: 526
Character Count: 3448

Document Content:

is concerned with the beneficial ownership of securities, and because beneficial ownership entails voting and investment power rather than simply record ownership, reporting persons must be aware of and report the securities transactions effected by all related persons and entities whose stock ownership is attributable to them under Section 16(a) (e.g., family members living in the same household, trusts, partnerships, and corporations). C. Covered Transactions Section 16(a) applies to virtually every form of change in beneficial ownership of securities. Purchases and sales, gifts, contributions to trusts, stock option grants and exercises, restricted stock grants, stock grants under deferred compensation plans, intra-plan transfers involving an issuer equity security fund, Rule 10b5-1 plan transactions, and other transfers of securities must be reported on a Form 4 filed with the SEC before the end of the second business day following the day on which the transaction is executed. D. Reports to the Company

The reporting requirements on Forms 3, 4 and 5 are the personal
obligation of the reporting person. The Company will assist the reporting person in complying with these reporting requirements. In
order to enable the Company to complete and file the reports on the reporting person’s behalf, the reporting person must immediately notify
the Company when a transaction is consummated. This notification must be received by the Secretary not later than the first business day
after the date on which the transaction occurs and must include the following information: (i) date of transaction; (ii) number of shares
acquired or disposed of; (iii) price per share; and (iv) number of shares beneficially owned at the end of the month.

In addition, the Company will notify reporting persons monthly of the
number of shares of Company stock which are shown on the Company’s records as being beneficially owned by them as of the end of each month.
The reporting person must reconcile this information if it is incorrect.

E.	Possible Sanctions

Any late or delinquent Form 4 filings are required to be reported in
the Company’s proxy statement. In addition, the SEC has been granted broad authority to seek “any equitable relief that may be appropriate
or necessary for the benefit of investors” for violations of any provision of the federal securities laws. Such relief could take
the form of SEC enforcement proceedings that result in civil or criminal penalties, including monetary fines and imprisonment in particularly
egregious cases.

F.	Sales of “Control” and Restricted Stock Pursuant to Rule 144

The Company will also assist directors and officers with the reporting
requirements for sales under Rule 144 promulgated under the Securities Act of 1933, as amended. Questions about Rule 144 should be
addressed to the Secretary prior to the consummation of a transaction.

IV. ACKNOWLEDGMENT AND CERTIFICATION

All Company insiders are required to sign the attached acknowledgment
and certification.

ACKNOWLEDGMENT AND CERTIFICATION

The undersigned does hereby acknowledge receipt
of the Company’s Insider Trading Policy. The undersigned has read and understands (or has had explained)
such Policy and agrees to be governed by such Policy at all times in connection with the purchase and
sale of securities and the confidentiality of nonpublic information.

(Signature)

(Please print name)

Date: ________________________